(Q39175682)
Statements
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo (English)
Alessandro Antonelli
Guido Bocci
Silvia Martina Ferrari
Poupak Fallahi
Alda Corrado
Anna Fioravanti
Paola Orlandi
Simona Piaggi
Alessandro Corti
Gabriele Materazzi
David Galleri